Jay Heller, VP, Head of Capital Markets, Nasdaq In 2024, we proudly welcomed leading IPOs including Lineage, Kaspi.kz, Waystar, BrightSpring Health Services, and Onestream. You're in great company ...

IPO activity looks likely to stay in an uptrend into mid-year – especially in the U.S. Of course, a lot can change over the course of a year, so we’ll be updating our Nasdaq IPO Pulses each ...

On the other side of the healthcare industry, the pharmaceutical sector has already had its fair share of IPOs this year. Weight loss drug developer Metsera is targeting $289m in its Nasdaq IPO while ...

TOKYO and NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Spirit Advisors LLC proudly announces the successful completion of the initial public offering (IPO) of PicoCELA Inc. (Nasdaq: PCLA), a pioneer in ...

Nasdaq (Nasdaq: NDAQ) announced today that in 2024, it welcomed 171 initial public offerings (IPOs), raising a total of $22.7 billion. A total of 123 operating companies and 48 SPACs listed on ...

HW Electro Co., Ltd. (New Filing – NASDAQ) (HWEP) plans to raise $16 million in an IPO on Tuesday, January 21st, IPO Scoop reports. The company will be issuing 4,000,000 shares at $4.00 per share.

The California-based company is set to begin trading on the Nasdaq, with 7.5 million shares priced between $14 and $16 apiece under the ticker BBNX—an IPO range that would give Beta Bionics ...

Maze Therapeutics ( NASDAQ: MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...

And based on our IPO Pulses, IPO activity looks likely to stay in an uptrend into mid-year – especially in the U.S. Of course, a lot can change over the course of a year, so we’ll be updating our ...